Adam Maeder
Stock Analyst at Piper Sandler
(4.61)
# 924
Out of 5,044 analysts
347
Total ratings
54.3%
Success rate
11.3%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Reiterated: Buy | $195 | $165.69 | +17.69% | 19 | Oct 8, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $470 | $423.96 | +10.86% | 53 | Oct 7, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $60 | $68.89 | -12.90% | 51 | Oct 2, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $101 | $85.21 | +18.53% | 57 | Sep 21, 2026 | |
| LIVN LivaNova | Reiterated: Buy | $87 → $90 | $76.39 | +17.82% | 34 | Sep 2, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $118 | $99.60 | +18.47% | 20 | Aug 26, 2026 | |
| STAA STAAR Surgical Company | Reiterated: Hold | $33 | $21.67 | +52.28% | 7 | Aug 13, 2026 | |
| RMD ResMed | Reiterated: Hold | $233 → $225 | $230.05 | -2.20% | 8 | Aug 7, 2026 | |
| RXST RxSight | Reiterated: Hold | $10 | $4.81 | +107.90% | 10 | Aug 6, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $9 | $8.89 | +1.24% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.521 | +475.82% | 8 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3.5 | $1.11 | +215.32% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $22.44 | +87.17% | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 → $3 | $2.13 | +40.85% | 13 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.5 → $7 | $0.05 | n/a | 12 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $48.73 | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.55 → $2.13 | $0.15 | n/a | 2 | Dec 23, 2019 |
Glaukos
Oct 8, 2026
Reiterated: Buy
Price Target: $195
Current: $165.69
Upside: +17.69%
Intuitive Surgical
Oct 7, 2026
Reiterated: Buy
Price Target: $470
Current: $423.96
Upside: +10.86%
Inspire Medical Systems
Oct 2, 2026
Reiterated: Hold
Price Target: $60
Current: $68.89
Upside: -12.90%
Edwards Lifesciences
Sep 21, 2026
Reiterated: Buy
Price Target: $101
Current: $85.21
Upside: +18.53%
LivaNova
Sep 2, 2026
Reiterated: Buy
Price Target: $87 → $90
Current: $76.39
Upside: +17.82%
Abbott Laboratories
Aug 26, 2026
Reiterated: Buy
Price Target: $118
Current: $99.60
Upside: +18.47%
STAAR Surgical Company
Aug 13, 2026
Reiterated: Hold
Price Target: $33
Current: $21.67
Upside: +52.28%
ResMed
Aug 7, 2026
Reiterated: Hold
Price Target: $233 → $225
Current: $230.05
Upside: -2.20%
RxSight
Aug 6, 2026
Reiterated: Hold
Price Target: $10
Current: $4.81
Upside: +107.90%
Sight Sciences
Aug 6, 2026
Reiterated: Buy
Price Target: $9
Current: $8.89
Upside: +1.24%
Jul 31, 2026
Reiterated: Buy
Price Target: $3
Current: $0.521
Upside: +475.82%
May 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $1.11
Upside: +215.32%
May 5, 2026
Reiterated: Buy
Price Target: $42
Current: $22.44
Upside: +87.17%
Apr 7, 2026
Reiterated: Buy
Price Target: $5.5 → $3
Current: $2.13
Upside: +40.85%
Aug 13, 2025
Reiterated: Hold
Price Target: $8.5 → $7
Current: $0.05
Upside: n/a
Apr 9, 2020
Initiated Coverage: Buy
Price Target: $74
Current: $48.73
Upside: n/a
Dec 23, 2019
Reiterated: Buy
Price Target: $3.55 → $2.13
Current: $0.15
Upside: n/a